Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Exogenous Progesterone as Ovulation Trigger [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating exogenous progesterone as an ovulation trigger, sponsored by Instituto Valenciano de Infertilidade de Lisboa, currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Instituto Valenciano de Infertilidade de Lisboa | Conditions: Ovulation, Ovarian Function | Phase 4 | Status: NOT_YET_RECRUITING